Latest stories on IONS
Ionis Pharmaceuticals, Inc. (IONS) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
Seeking Alpha56 · neutralgeneral
Cathie Wood Is Loading Up on Ionis Pharmaceuticals (IONS) Stock. Here's the Bet She's Making.
Yahoo Top63 · neutralanalyst
Cathie Wood Is Loading Up on Ionis Pharmaceuticals (IONS) Stock. Here's the Bet She's Making.
The Motley Fool63 · neutralanalyst
Ionis Pharmaceuticals price target lowered to $85 from $90 at Barclays
The Fly38 · neutralanalyst
Raymond James cuts Ionis Pharmaceuticals price target on trial miss
Investing.com Analyst Ratings32 · bearishanalyst
Ionis Pharmaceuticals price target lowered to $84 from $87 at Raymond James
The Fly34 · bearishanalyst
Amgen drops on Novartis trial setback for heart therapy; BMO downgrades
Seeking Alpha34 · bearishgeneral
H.C. Wainwright cuts Ionis stock price target to $100 on pelacarsen removal
Investing.com Analyst Ratings34 · bearishanalyst
Ionis Pharmaceuticals price target lowered to $104 from $110 at Morgan Stanley
The Fly42 · neutralanalyst
Canaccord cuts Ionis stock price target to $85 on pelacarsen trial miss
Investing.com Analyst Ratings34 · bearishanalyst
Ionis Pharmaceuticals price target lowered to $84 from $94 at TD Cowen
The Fly38 · neutralanalyst
Ionis Stock Sinks 10% as Analysts Cut Targets After Pelacarsen Trial Miss
TipRanks34 · bearishearnings
Ionis Pharmaceuticals price target lowered to $85 from $95 at Canaccord
The Fly38 · neutralanalyst
Ionis Pharmaceuticals price target lowered to $54 from $61 at BMO Capital
The Fly38 · neutralanalyst
Ionis Pharmaceuticals Shares Fall After Pelacarsen Phase 3 Trial Misses Primary Endpoint
InvestorsHub28 · bearishearnings
Ionis Pharmaceuticals price target lowered to $56 from $69 at Goldman Sachs
The Fly34 · bearishanalyst
Why is Ionis Pharmaceuticals stock tumbling today?
Investing.com Markets34 · bearishgeneral
Ionis Pharmaceuticals price target lowered to $100 from $115 at H.C. Wainwright
The Fly38 · neutralanalyst
Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval and Launch Strategy for ZANVASTRO in Alexander Disease - Slideshow
Seeking Alpha73 · bullishproduct/pr
Citi sees limited immediate downside for Ionis after pelacarsen failure
The Fly42 · neutralanalyst
Stocks to Watch: Ionis Pharmaceuticals, Novartis, Corvex
Morningstar34 · bearishproduct/pr
Ionis Pharmaceuticals Updates on Novartis Pelacarsen Trial Outcome
TipRanks58 · neutralproduct/pr
IONIS PHARMACEUTICALS INC (IONS) files 8-K
SEC 8-K50 · neutralgeneral
Ionis Pharmaceuticals falls after Pelacarsen fails key Phase 3 heart trial
Seeking Alpha28 · bearishproduct/pr
Ionis Pharmaceuticals, Inc. (IONS) Discusses FDA Approval and Launch Strategy for ZANVASTRO in Alexander Disease Transcript
Seeking Alpha73 · bullishproduct/pr